3d Medicines (sichuan) Co., Ltd.

This study tests a drug called KN035 in people with advanced solid tumors that have specific genetic changes (dMMR or MSI-H). About 200 participants whose cancer has not responded to standard treatments will receive KN035 alone. The main goal is to see if the drug can shrink tumo…

This study tests a drug called envafolimab, given alone or with lenvatinib, in people with advanced endometrial cancer that has not responded to standard chemotherapy. The goal is to see if the treatment shrinks tumors. About 108 participants will take part. This is an early-phas…

This study is testing whether combining two drugs, Envafolimab and Lenvatinib, can shrink tumors in people with advanced solid tumors like lung, kidney, or liver cancer. About 170 adults whose cancer has worsened after standard treatments will receive the drug combination. The go…

This study tests a drug called Envafolimab in people with advanced solid tumors that have not responded to standard treatments. The goal is to see how well the drug works in tumors with high genetic mutations (TMB-H) compared to those with low mutations. About 126 adults will tak…

This study tests whether adding the drug envafolimab to standard chemotherapy can shrink tumors better than chemotherapy alone in people with stage III non-small cell lung cancer that can be surgically removed. About 390 adults will receive either the combination or a placebo plu…